Trial of Cholinergic Agonist in Adults with ADHD
Abstract
A novel cholinergic activating agent, ABT-418, was used to treat 29 adults with ADHD, in a double-blind, placebo-controlled, randomized, crossover trial at the Pediatric Psychopharmacology Clinic, Massachusetts General Hospital, Boston.
DOI: https://doi.org/10.15844/pedneurbriefs-13-12-10 | Journal eISSN: 2166-6482
Language: English
Page range: 95 - 95
Published on: Dec 1, 1999
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1999 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.